Yahoo Web Search

Search results

1. • Analyst Report: Merck & Co Inc

     Argus Research via Yahoo Finance· 1 day ago

     Merck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has ...

2. • 

     Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

     Zacks via Yahoo Finance· 4 days ago

     Pharmaceutical Intellidex Index is comprised of stocks of U.S. pharmaceutical companies. It is...

3. • Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

     Morningstar· 2 days ago

     Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive ...

4. • 

     MOBILion Shows Off MOBIE System at ASMS 2024

     Exec Edge via Yahoo Finance· 1 day ago

     By Karen Roman MOBILion Systems announced it is presenting the latest features of its mass spectrometry platform, MOBIE EyeOn 2.3, at the 72nd American...

5. • 

     U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.30% By Investing.com

     Investing.com· 3 days ago

     U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.30%

6. • Small Business - Shelby County Reporter | Shelby County Reporter

     The Shelby County Reporter· 2 days ago

     RNAi Therapeutics and Technology Market Worth USD 5.36 Billion by 2031 at 16.6% CAGR- Exclusive Report by InsightAce Analytic Pvt. Ltd. PR Newswire JERSEY CITY, N.J., June 4, 2024 JERSEY CITY, N.J., June 4, 2024 /PRNewswire/ -- InsightAce Analytic

7. • Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...

     The Woonsocket Call· 5 days ago

     Olomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS...

8. • 

     Deal Watch: Energy, Pharma Continue to Drive Deal Activity as Wachtell, Kirkland Lead $22.5 Billion...

     Law.com· 3 days ago

     The transaction is the latest in a series of consolidation moves in the energy sector, coming on the...

9. • Small Business - Picayune Item | Picayune Item

     The Picayune Item· 3 days ago

     The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient ...